The U.S. Food and Drug Administration's Center for Veterinary Medicine has announced that registration is now open for a virtual public listening session on the agency's regulation of animal foods with certain types of claims such as environmental benefits (e.g., reduced greenhouse emissions), production claims (e.g., growth promotion, feed efficiency), and claims about effects on the animal microbiome.

The virtual listening session will take place on Oct. 18, and offer stakeholders an opportunity to share information and insight with the FDA about the regulation of animal foods with certain types of claims. The listening session will start at 10 a.m. EDT. The end time will be determined based on the number of presentations submitted by interested stakeholders.  

The FDA is reviewing CVM Policy and Procedures Manual (PPM) 1240.3605, Regulating Animal Foods with Drug Claims, and is seeking public comments on how the existing policy could be updated to reflect evolving scientific knowledge and promote innovation. 

Stakeholders interested in attending the virtual listening session should register no later than Oct. 11, at 11:59 p.m. ET, by completing the registration form on the event webpage. Early registration is recommended. Registrants will receive a confirmation email with the event link and password.

If you are interested in presenting on the topic of regulation of animal foods with certain types of claims during the virtual listening session, fill out and submit the registration form on the event webpage no later than Sept. 20, at 11:59 p.m. EDT, and be sure to check the box indicating that you would like to present. The FDA will contact presenters by Sept. 27 with further instructions.

In addition to holding the listening session, the FDA is accepting electronic or written comments through Nov. 17. To electronically submit comments to the docket, visit the Regulations site and type "FDA-2022-N-2015" in the search box. To submit comments to the docket by mail, follow instructions on the FDA Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims webpage.

During quarter one of calendar year 2023, CVM intends to provide the public with additional opportunities to share input on other animal food-related topics such as the FDA's role in the AAFCO ingredient definition process. As details for these opportunities are finalized, the FDA will publicize them by posting information on its website.

Source: U.S. Food and Drug Administration, which is solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.